Wadden, T. (2022) “LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOR THERAPY IN INDIVIDUALS WITH OBESITY: SCALE IBT 56-WEEK RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL”, Journal of the ASEAN Federation of Endocrine Societies, 34(2), pp. 9–10. Available at: https://asean-endocrinejournal.org/index.php/JAFES/article/view/1853 (Accessed: 21 November 2024).